Treatment of chronic viral hepatitis

被引：23

作者：

Main, J ^{[1
]}

McCarron, B ^{[1
]}

Thomas, HC ^{[1
]}

机构：

[1] St Marys Hosp, Imperial Coll Sch Med, London W2 1NY, England

来源：

ANTIVIRAL CHEMISTRY & CHEMOTHERAPY | 1998年 / 9卷 / 06期

关键词：

hepatitis B; interferon; hepatitis C;

D O I：

10.1177/095632029800900601

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

interferon-alpha therapy has proved effective for up to 40% of patients with adult-acquired chronic hepatitis B virus (HBV) infection and for 20-25% of those with chronic hepatitis C virus (HCV) infection. Nucleoside analogues, such as lamivudine and famciclovir, are showing promise as antiviral agents for chronic HBV and the combination of interferon-alpha and ribavirin is proving to be successful therapy for 40-50% of patients with chronic HCV. In this article we review current therapy and discuss future strategies of the therapy of chronic viral hepatitis.

引用

页码：449 / 460

页数：12

共 112 条

[1] A ROLE FOR HEPATITIS-C VIRUS-INFECTION IN TYPE-II CRYOGLOBULINEMIA [J].

AGNELLO, V ;

CHUNG, RT ;

KAPLAN, LM .

NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (21) :1490-1495

[2]

[Anonymous], 1997, HEPATOLOGY, V26, pS2

[3] Hepatitis B virus polymerase mutations during antiviral therapy in a patient following liver transplantation [J].

Aye, TT ;

Bartholomeusz, A ;

Shaw, T ;

Bowden, S ;

Breschkin, A ;

McMillan, J ;

Angus, P ;

Locarnini, S .

JOURNAL OF HEPATOLOGY, 1997, 26 (05) :1148-1153

[4] Molecular targets in inhibition of hepatitis C virus replication [J].

Bartenschlager, R .

ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, 1997, 8 (04) :281-301

[5] Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation [J].

Bartholomew, MM ;

Jansen, RW ;

Jeffers, LJ ;

Reddy, KR ;

Johnson, LC ;

Bunzendahl, H ;

Condreay, LD ;

Tzakis, AG ;

Schiff, ER ;

Brown, NA .

LANCET, 1997, 349 (9044) :20-22

[6]

BASSENDINE MF, 1981, GASTROENTEROLOGY, V80, P1016

[7]

BELLOBUONO A, 1994, J HEPATOL S, V21, P35

[8] Estimates of the cost-effectiveness of a single course of interferon-alpha 2b in patients with histologically mild chronic hepatitis C [J].

Bennett, WG ;

Inoue, Y ;

Beck, JR ;

Wong, JB ;

Pauker, SG ;

Davis, GL .

ANNALS OF INTERNAL MEDICINE, 1997, 127 (10) :855-+

[9] Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation [J].

Bizollon, T ;

Palazzo, U ;

Ducerf, C ;

Chevallier, M ;

Elliott, M ;

Baulieux, J ;

Pouyet, M ;

Trepo, C .

HEPATOLOGY, 1997, 26 (02) :500-504

[10]

BLOOMER J, 1997, HPEATOLOGY, V25, pA1199

← 1 2 3 4 5 6 7 8 9 10 →